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Arguments foran involvement of bacteria in the pathogenesis ofchronicjoint inflam-
mation (arthritis) are several (1-12). To studythepathogenetic mechanism ofbacterium-
induced sterile arthritis, different animal models are used, among which, Mycobac-
terium tuberculosis-induced or adjuvant arthritis (AA)t (2) and streptococcal cell wall
(SCW)-induced arthritis (1) are the bestknown . In both models, bacterium-specific
T lymphocytes have been demonstrated to play a crucial role (13-24, and van den
Broek,M. F, M. C. J. van Bruggen, A. J . Severijnen, andW B. van den Berg,
manuscript submitted forpublication), andone aspect ofthis role mightbe the cross-
reactive nature oftheseT lymphocytes to cartilage-associated components (22, 25) .
In AA it is a well knownfact that rats that have recovered from arthritis are resis-
tant to asubsequent induction ofAA (17, 18), and it has been demonstrated recently
that pretreatment ofrats with themycobacterial 65-kD protein resulted in the same
resistance to AA when tested 35 d later (13) . Since the 65-kD protein is an ubiqui-
tous bacterial common antigen (26), with a homologous molecule present also in
streptococci, and probably even associated with cell walls (27), we tested the effects
ofpretreatment with the mycobacteria165-kD protein on the development ofSCW
arthritis .
Here we show that intraperitoneal administration of 50 lAg 65-kD protein to rats
35, 25, 15, or even as short as 5 d before induction ofSCW arthritis completely
protected the rats against the chronic erosive polyarthritis . The resistance against
SCW arthritis is transferrable by spleen T cells to naive recipients . The protection
coincides with a suppression of SCW-specific T cell responses, thus displaying fea-
tures much alike suppression or tolerance leading to resistance in other models for
autoimmune diseases (28-31) .
This work wassupported by de Nederlandse Vereniging voor Reumabestrijding(Dutch League Against
Rheumatism) . Address correspondence to Maries F . van den Broek, Department of Rheumatology,
University Hospital Nijmegen, Geert Grooteplein zuid 8, 6525 GA Nijmegen, The Netherlands .
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￿
'Technetium.
J . EXP. MED. ® The Rockefeller University Press - 0022-1007/89/08/0449/18 $2.00
￿
449
Volume 170 August 1989 449-466450
￿
65-kD PROTEIN PROTECTS AGAINST ARTHRITIS
Materials and Methods
Rats.
￿
Female Lewis rats were obtained from the Zentral Institut fur Versuchstierzucht
(Hannover, FRG). The rats were housed in our animal laboratory and were fed a standard
diet and tap water ad lib. Rats weighed 100-125 g at the start of the experiments.
SCW.
￿
Streptococcus pyrogenes T12 organisms were cultured in Todd-Hewitt broth and har-
vested after 24 h. The bacteria were mechanically disrupted and subsequently treated with
various degrading enzymes as described (1). Further isolation was carried out by differential
ultracentrifugation steps, as has been described (32), and the resulting 100,000-g pellet was
used throughout the experiments. This preparation contained 12 .8% muramic acid (33). The
SCW were kindly provided by Dr. A. J . Severijnen, Erasmus University, Rotterdam, the
Netherlands.
Induction of SCW Arthritis.
￿
To induce a chronic polyarthritis, rats were injected in-
traperitoneally with a sterile aqueous suspension of SCW at a dose of 15 Rg muramic acid
per gram rat body weight. The arthritis was scored macroscopically by measuring paw thick-
ness with a caliper, and by histology.
Induction ofAdjuvantArthritis.
￿
Lewis rats were injected intracutaneously at the base of the
tail with 1 mg heat-killed M. tuberculosis organisms (H37Ra; Difco Laboratories, Inc., Detroit,
MI) suspended, but not emulsified, in oil (2). Polyarthritis occurred after 14-16 d and lasted
N4 wk.
Induction ofZymosan Arthritis.
￿
To induce a nonimmune arthritis, 6 pl of a sterile suspension
of zymosan (10 mg/ml) (Koch-Light Lab., Coinbrook, Bucks, UK) in PBS was injected into
the right kneejoint (34). The control joint was injected with 6 Al PBS. Because the resulting
arthritis was a unilateral one, it could be quantified by the ' 9mTechnetium (1c)-uptake method
as previously described (35). Briefly, rats were sedated with pentobarbital and injected with
1 MBq 99-Tc. After 20 min, radioactivity in the right and left knee joint was measured by
external gamma counting. Arthritis was expressed as the ratio of 99-Tc uptake between right
and left joint. All ratios >1.10 were interpreted as inflammation.
Induction ofDelayed-type Hypersensitivity (DTH) Reaction.
￿
To analyze the effect of pretreat-
ment with 65-kD protein on cellular immune responses, we immunized 65-kD protein-pre-
treated and IFA-pretreated control rats with OVA or with OVA + SCW emulsified in IFA
by injection of 100 ul (1 mg/ml) of the emulsion into the footpads of the forepaws. A DTH
reaction as a measure of cellular immunity was induced by injection of 10 kg OVA into the
right, and saline into the left, ear of rats. The resulting swelling of the ears was measured
6, 24, and 48 h thereafter. The swelling is expressed as right over left ratios.
Pretreatment with Recombinant 65-kD Mycobacterial Protein.
￿
The 65-kD protein of various
Mycobacterium species has recently been cloned and expressed in Escherichia coli K12 M1070
(36-38). The recombinant 65-kD protein was prepared from E. coli carrying plasmid pRIB1300.
Induced cultures were resuspended in 100 mM Tris, 5 mM EDTA, pH 8, and sonicated by
eight pulses of 30 s at 80 W. The resulting lysate contained the 65-kD protein up to 30%.
The protein was purified from the lysate by ammonium sulphate precipitation followed by
DEAE column chromatography as described (39). The isolated protein was checked for pu-
rity by SDS-PAGE (Fig. 1).
Lewis rats were treated by intraperitoneal injection of 50 p.g 65-kD protein suspended in
IFA. Control rats were injected with IFA alone.
Transfer of 65-kD Protein-induced Protection.
￿
To investigate whether the 65-kD protein-in-
duced protection against SCW arthritis was mediated by cellular immunity, transfer experi-
ments were done. For this purpose, we injected Lewis rats intraperitoneally with 50,ug 65-kD
protein/IFA or with IFA alone. After 20 d, we removed the spleen. From spleens a single
cell suspension was made. The cells were washed once with RPMI 1640 dutch modification
(dm) (Flow Laboratories, Inc., McLean, VA) and the erythrocytes were lysed with 0.16 M
NH4C1/0.17 M Tris-HCI, pH 7 .2, for 2 min at room temperature. The white cells were
washed twice with RPMI 1640 dm. Subsequently, the cells were incubated for adherence
to a culture flask in RPMI 1640 dm supplemented with 20 mM glutamine and 2 % (vol/vol)
SFl (Costar, Cambridge, MA) as serum substitute for 45 min at 37 0C in a C02 incubator.
The nonadherent cells were collected by aspiration. Thesecellswere pelleted and resuspendedVAN DEN BROEK ET AL .
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in 1 ml RPMI 1640 dm + glutamine + SF1 and were applied to a nylon wool column for
further removal ofadherent cells. After 45 min in a C02 incubator at 37°C, the nonadherent
population was eluted with 25 ml warm RPMI 1640 dm. Of the resulting population, 95%
or more of the cells were W3/13* .
Naive Lewis rats were injected intravenously with 5 x 108 total spleen cells or with 5 x
107 spleen T cells. Immediately thereafter, SCW were injected intraperitoneally to induce
arthritis as described above.
Proliferative ResponseofSpleen T Cells.
￿
Spleens were removed aseptically from rats 4 wk after
intraperitoneal SCW injection and a single cell suspensionwas made. T cell-enriched spleen
cells (see above) were incubated in microtiter round-bottomed plates (Costar) with the fol-
lowing stimuli: SCW (6-2-0.6 jig/ml muramic acid), 65 kD (30-10-3 hg/ml), and Con A (1.25
ug/ml). The final density of cells was 105/200
JAI RPMI 1640 dm + 10 mM glutamin + 2
SFl + 40 FAg/ml gentamycin.
After 3 d, 3.7 x 104 Bq (1 EACi) [3H]thymidine (Amersham, Amsterdam) (0.7-1.1 x 108
MBq/mmol sp act) was added per well. 24 h thereafter, the cells were harvested onto glass
fiberfilters and the amount of incorporated radioactivity was counted in a liquid scintillation
analyzer. All values are expressed as the mean of at least triplicate cultures.
ELISAfor Anti-65-kD Protein orAnti-SCWAntibodies.
￿
96-well flat-bottomed microtiter plates
were precoated with 150,.1 0.5 mg/ml protamine-HCI (Kabi AB, Stockholm, Sweden) for
2 h in the case of an SCW-specific plate. Precoating was not necessary for 65-kD ELISA.
After three washes with PBS + 0.05% (vol/vol) Tween-20, plates were coated with 65-kD
protein and native or denatured SCW (10 min, 100°C, 1 :1 diluted with 10% glycerol, 5%
(3-mercaptoethanol, 5% SDS), 5 /~g/ml, 150 pl/well overnight. The plates were washed three
times and postcoated to avoid nonspecific binding with 150 J.1/well 1 % (wt/vol) BSA for 2 h.
The plates were incubated with 100 /.d/well oftwofold dilutions ofpooled rat sera in 1% (wt/vol)
BSA for 1 h. The plates were washed five times and then incubated with 100 pl/well horse-
radish peroxidase-conjugated goat-anti-rat Ig (Nordic, Tilburg, the Netherlands) diluted
500 times in 0.5% (wt/vol) BSA for 1 h. After five washes, 100 JAI of the following freshly
prepared substrate solution, 0.8 mg/ml 5-aminosalicylic acid dissolved in 50 mM phosphate
buffer, pH 6.0, containing 0.8 Al/ml 30% (vol/vol) H202, was added to each well. After 30
min, the absorbtion at 450 nm was measured in a Titertek Multiskan (Flow Laboratories,
Irvine, Scotland). All values were corrected for the signal obtained by omitting the antigen-
coating step. All incubations were carried out at room temperature.
ImmunologicalRelationship between SCWandMycobacterial 65-kD Protein.
￿
To investigate whether
on 65-kD protein and SCW similar T cell epitopes were present, rats were immunized in
the footpads of the forepaws with 65-kD protein or SCW emulsified in IFA. 9 d thereafter,
draining lymph nodes were removed aseptically and a single cell suspension was made. The
cells were stimulated in vitro with 65-kD protein (10, 3, and 1 pg/ml), SCW (6, 2, and 0.6
kg/ml muramic acid), and mitogen (Con A; 1.3 Rg/ml), and the resulting proliferative re-
sponse was measured as described above.
To test serological relationship between the mycobacteria165-kD protein and SCW several
65-kD protein-specific mAbs and polyclonal sera were tested for binding to 65-kD protein
and SCW in ELISA as described above. In the ELISA system, blocking studies were per-
formed as follows: 1 :200 diluted anti-SCW or anti-65-kDprotein sera were incubated over-
night at 37°C with different concentrations of inhibitor (65 kD protein or SCW). Subse-
quently, the sera were placed at 4°C for 2 h to favor the formation of complexes and the
sera were centrifuged (10 min, 2,000 rpm). The "supernatants" were tested in an ELISA as
described above. In addition, antibodies were tested on a Western blot as follows: SCW and
65-kD protein were incubated with a similar volume ofdenaturingbuffer (0.01 % bromophenol
blue, 10% glycerol, 5% /3-mercaptoethanol, 5% SDS for 10 min at 100'C. The samples were
separated using a 10% SDS-polyacrylamide gel. The material was electroblotted onto nitrocel-
lulose (4 h, 60 V, 0.2 A) using the following buffer: 200 ml ethanol + 3 g Tris + 14.4 g
glycine + 0.3 g SDS/liter. Nitrocellulose (NC) strips were incubated with blocking buffer
(PBS + 2% BSA) for 2 h and subsequently with 1 :200 diluted sera or mAbs in washing
buffer (PBS + 1% Triton X-100 + 0.1 % SDS + 0.5% BSA) and the appropriate peroxidase-452
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conjugated antisera (Nordic, Tilburg, the Netherlands) in a dilution of 1/500 for 1 h. NC
strips were washed between each step for 3-5 min . Finally, the strips were incubated with
freshly prepared substrate : 0.5 mg/ml4-chloro-l-naphtol + 0.015% H202 in water. The reac-
tion was stopped with water.
Histology ofKneeJoints.
￿
Ankle joints were removed andprocessed for histology as described
(40) with the following alterations : formalin for 2 wk and HCOOH for 2 wk. 7-Pm paraffin
sections were made and stained with hematoxilin and eosin . Scoring of inflammation was
done by two independent observers on coded slides . A scale of 0-3 was used to quantify the
amount of infiltrate and exudate.
Results
Effect ofPretreatment with the Mycobacterial 65-kD Protein on SCW-induced Arthritis
Joint Inflammation . It has been described (13) that pretreatment by intraperitoneal
injection of 50 Ag 65-kD protein/IFA (Figure 1) 35 d before challenging with the
wholeM. tuberculosis in oil protected Lewis rats against adjuvant arthritis. To investigate
whether this particular protein was similarly protective in another bacterium-induced
arthritis model, we tested the same treatment regime in SCW-induced arthritis in
Lewis rats . Fig . 2 shows the arthritis in pretreated and control rats as measured by
thickness of the hind paws . Complete protection against arthritis was found in the
group pretreated with 65-kD protein/IFA, while in the controls, a severe, erosive
polyarthritis was seen . Additional experiments were undertaken to evaluate the ki-
netics of the pretreatment effects (Fig . 2) . Intraperitoneal injection of 50,ug 65-kD
protein/IFA 35, 25, 15, or 5 d before induction ofSCW arthritis completely pro-
tected rats againstjoint inflammation . The histology of arthritic and protectedjoints
is shown in Fig. 3, A and B . Fig . 3 A shows a severely inflamed joint, while Fig .
3 B, pretreatedon day -25, shows only marginal inflammation . Jointsfrom rats that
were pretreated 35, 15, or 5 d before SCW arthritis induction show the same histology
(data not shown) . Besides the massive infiltrate and exudate in the joint space and
bone marrow ofcontrol rats (Fig. 3 A), also a complete destruction ofcartilage, muscle,
and bone structures is observed .
In addition, at autopsy it became clear that in successfully protected rats some
FIGURE 1 .
￿
SDS-PAGE from the isolated mycobacterial 65-kD heat shock
protein that was used throughout the studies . (A) Molecular weight
markers : 200, 116, 95 .5, 66.2, 45, 31, and 21.5 kD ; (B, C, and D) 4, 2,
and 1 Wg purified mycobacterial 65-kD protein, respectively .VAN DEN BROEK ET AL.
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other characteristics of SCW disease, like granulomas in the liver, adhesions of the
spleen, and loss of body weight, were absent (data not shown).
Administration of 50 Ag 65-kD protein during arthritis (day 15, 35, or 55 after
SCW injection), however, did notlead to an amelioration of arthritisbutto asignificant
visual (redness and swelling) and functional (limping) deterioration instead.
Immune Response to SCWand65-kD Protein in SCWArthritis andProtectedRats.
￿
Be-
cause expression of SCWinduced arthritis is dependent on T cells (14-16), and in
all probability on SCWspecific ones (16, van den Broek, M. F, M. C.J. vanBruggen,
A. J. Severijnen, and W B. van den Berg, manuscript submitted for publication),
we investigated the relation between arthritis and SCWspecific T cell responses in
sucessfully protected rats and control rats. Table I shows spleen T cell proliferation
in response to mitogen, SCW or 65-kD protein (>95% W3/13+, data not shown).
Cells were obtained 30 d after intraperitoneal injection of an arthritogenic dose of
SCW SCW-specific and 65-kD protein-specific Tcell responses are clearly present
in arthritic (IFA-pretreated) rats, as compared with naive control rats.
In protectedrats, pretreated with 65-kD protein at day -5 or -15, theresponses
to SCW, 65-kD protein, and mitogen are significantly lower than those in arthritic
rats. Thus, the 65-kD protein-induced protection against SCW arthritismay result
from specific Tcell regulation. Proliferative responses ofT cell-enriched spleen cells
obtained from rats pretreated at day - 25 or -35 are similarto thoseshown in Table
I for rats pretreated at day -15 or -5 (data not shown).
Pretreatment with 65-kD protein had no effect on antibody levels to SCW, but
the antibody levels against65-kD protein showed apositive correlation with thetime454
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FIGURE 3 .
￿
Histology ofSCW arthritis: frontal sectionsofrat ankle joint . StainingH&E. JS, joint
space ; S, synovium ; B, bone ; C, cartilage. (A) Pretreated with IFAon day -25(x 40) . (B) Pretreated
with 65-kD protein/IFA on day -25 (x 40) . Note the mass ofinflammatory cells in thejoint space
and bone marrow, leading to a complete joint distruction .VAN DEN BROEK ET AL.
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TABLE I
Proliferative Responses of 105 T Cell-enriched Spleen Cells of
Rats, Isolated 30 d after Intraperitoneal Injection ofan
Arthritogenic Dose of SCW orfrom Naive Rats
Proliferative responses (SIs) at day 30 of:
Proliferation was measured by [3H]thymidine incorporation during the last 16 h
of a 96-h culture with various stimuli. Proliferative responses are expressed as
stimulation indices (amount ofradioactivity incorporated due to stimulus Xdivided
by that due to medium alone). The values represent the mean of at least tripli-
cate cultures and the variation was always <10% . Spleens from each goup were
pooled.
elapsed between 65-kDprotein injection andserum sampling, as expected(datanot
shown). This indicated that although pretreatment with 65-kD protein suppressed
SCW-specific Tcell responses and SCW-induced arthritis, it had no effect on anti-
SCW antibody levels.
Transfer ofProtectionby T Cells.
￿
Fig. 4 showsthe severityofSCW arthritisin Lewis
rats that were injected intravenously at the day ofarthritis induction (day 0) with
5 x 10$ spleen cells (A) or with 5 x 107 spleen T cells (B) obtained from rats pro-
tected by 65-kD protein pretreatment or IFA-pretreated control Lewis rats. It is ob-
vious that both total spleen cells and spleen Tcells from protected rats were able
to transfer this protection to naiverecipient rats, whilespleen cells from control rats
were not. In the group receiving total spleen cells, the transferred protection was
not complete, however, one ofsix ratsdeveloped a SCW arthritis almost as severely
as those in the control group, but less chronic. Another rat alsoshowed asubstantial
arthritis, although significantly less severe than that in control rats. The other four
rats had a very mild arthritis with a delayed onset (2 wk) and a short duration. In
the group receiving spleen T cells, the protection was complete in all recipients,
even at a 10-fold lower transferred cell number. These results suggest that the pro-
tection against SCW arthritis induced by pretreatment with 65-kD proteinis medi-
ated by T cells.
Efect ofRecovery from AA on SCWArthritis Susceptibility
It is known that rats that have recovered from AA are resistant to a subsequent
AAinduction(17, 18). To investigate whetherSCWinduced arthritis is alsoprevented
Antigen Dose
pg/ml
Rats injected
65-kD protein
at day - 15
with SCW i
65-kD protein
at day - 5
(day 0)
IFA
at day -
Naive rats
15 None
SCW 6 4 5 40 2
2 2 2 26 1
0.6 1 1 4 1
65-kD protein 10 3 4 26 8
3 2 2 8 3
1 1 1 2 1
Con A 1 .3 7 6 212 149456
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￿
Transfer of65-kD-induced
protection againstSCWarthritis: donor
rats were injected intraperitoneallywith
50 gg 65-kD protein/IFA or with IFA
aloneat day -20. At day0spleen cells
were isolated and 5 x 108 cells (A) or
5 x 10'purified spleen Tcells (B)were
injected intravenously into recipient
rats. Immediatelythereafter an arthrito-
genic dose of SCWwas injected intra-
peritoneally. SCW arthritis is measure
as the sum of the thickness of both
hindlegs x 0.1 mm. (A)Each groupcon-
sistedof sixrats. Themean value t SD
is shown of rats which received IFA
spleen cells (A), andindividual values
of rats that received 65-kD spleen cells
areshown. (B)Each groupconsisted of
four rats. The mean value t SD ofrats
injected with IFAsplenicT cells (O)of
65-kD splenic T cells(*) is shown.
by a foregoing AA, we induced SCW arthritis in rats that had recovered from AA
(35 d after induction). However, all ex-AA rats died between 6 and 16 h after in-
traperitonealSCWadministration, showingedematouslungsandhemorrhagiclymph
nodes at autopsy, while controlrats (injectedwith IFA alone insteadof IFA/M. tuber-
culosis) developed a normal SCW arthritis (Table II).
When rats were injected with whole Streptococcus pyogenes organisms suspended in
IFA in the adjuvant-like manner (0.1 ml intracutaneously, 10 mg/ml), an adjuvant-
like polyarthritis developed within 2 wk, which resolved after-40 d. Injection with
an aqueous suspension SCW (arthritogenic dose) after resolution ofdisease did not
result in death of rats recovered from streptococcus arthritis, but led to a reactiva-
tion of thejoint swelling and redness within several hours instead, thus suggesting
an accelerated onset of SCW arthritis. Summarizing, immunization with M. tuber-
culosis (and the resulting arthritis) leads to a lethal hypersensitivity upon challengeVAN DEN BROEK ET AL.
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TABLE II
Effect of Pretreatment with M. Tuberculosis on the Expression of
SCW-induced Arthritis
Effect of pretreatment with M. tuberculosis (Mt) in oil (adjuvant arthritis), its
immunodominant 65-kD protein in oil, orS. pyogenes (Sp) in oil (streptococcus
arthritis) on the expression of SCW-induced arthritis. Rats were pretreated
35 d before intraperitoneal administration of Sew. Arthritis was scored by
measuring joint swelling and by histology.
` Rats died within 24 h after challenge.
$ One rat did not die, but developed only the T cell-independent acute phase.
s All rats developed a severe arthritis with accelerated onset (within 48 h, nor-
mal Sew
arthritis develops after 11-14 d).
with SCW. This phenomenon is not seen after the immunization with S pyogenes
(and the resulting arthritis).
Effect ofPretreatment with theMycobacterial65-kDProtein on Zymosan-inducedArthritis
To exclude the possibility that the observed protection against SCW arthritiswas
a nonspecific andinflammatory effect of the 65-kD mycobacterialprotein, we tested
the effect of pretreatment with this protein on a nonimmune joint inflammation,
zymosan-induced arthritis (34). Arthritis is quantified by determining the ratio of
"Tc uptake in the right (arthritic) over the left (control)joint. The amount of 99"'Tc
is influenced by edema and increased bloodflow. In both groups the R/L ratios were
comparable: 4 d after zymosan injection the mean ratio t SD of the IFA-treated
group was 1.33 t 0.04 (n = 5) and that of the 65-kD protein-treated group was
1.29 t 0.04 (n = 5). Also, histologically, no difference between the two groups was
observed (datanot shown). Theseresultsindicate that 65-kD protein is notanonspecific
andinflammatory agent.
Effect of Pretreatment with the Mycobacterial 65-kD Protein on a DTH Reaction
To excludethat theprotection against bacterialarthritisby 65-kDproteinis medi-
ated by a nonspecific immunosuppressive capacity ofthe mycobacterial protein, we
analyzed the effect of 65-kD protein pretreatment on the cellular immune response
in vivo, a DTHreaction. Rats were pretreated 20 dbefore immunization with 50 hg
65-kD protein/IFA or with IFA alone. Table III shows the ear swelling in the four
groups as aresult from challenge with OVA. In 65-kDprotein-pretreated and control
OVA-primed groups, acomparable swelling is observed, thus implying that the effect
of 65-kD protein on bacterial arthritis is not a nonspecific immunosuppressive one.
To test whether 65-kD protein primes for suppression that can be activated by
Pretreatment Condition of rats at day 60
Day 0 Day 35 Dead Arthritic Nonarthritic
- Mt/oil 0 20 2
Mt/oil Mt/oil 0 0 10
65 kD/oil Mt/oil 0 0 10
- sew 0 20 0
Mt/oil sew 13` 11 0
65 kD/oil sew 0 0 14
Sp/oil sew 0 los 0458
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TABLE III
Effect of Pretreatment with 65-kD Protein/IFA or IFA Alone on a
DTH Reaction as Measure for a Cellular Immune Response In Vioo
R/L ratio of ear swelling of rats immunized at day - 14 with:
Pretreatment
￿
OVA/IFA
￿
OVA + SCW/IFA
at day - 34
￿
24 h
￿
48 h
￿
24 h
￿
48 h
65AD protein/IFA
￿
2 .18 ± 0.08
￿
1 .71 t 0.11
￿
1.32 t 0.03'
￿
1 .21 t 0.05
IFA
￿
2.11 t 0 .11
￿
1 .64 f 0.07
￿
1 .96 t 0.08
￿
1 .69 t 0.07
DTH was induced by injection of 10 p.g OVA into the pinna of the right and saline into
the pinna ofthe,left ear of rats, which were treated as follows: day - 34, pretreatment with
65-kD protein/IFA (n = 6) or IFA (n = 6) intraperitoneally; day - 14, immunization with
OVA/IFA or OVA + SCW/IFA in forepaws; day 0, intrapinnal challenge with OVA; day
1 and 2, measurement of DTH reaction.
P < 0.001 compared with its IFA-pretreated control group as determined by the two-tailed
Mann Whithey U test.
rechallenge with a 65-kD protein-containing antigen, we immunized 65-kD-pro-
tein-pretreated and control rats with OVA/IFAsupplemented with SCW to activate
this suppression and induced aDTH with OVA subsequently. TableIII depicts that
the OVA-elicited DTH reactions in OVA/IFA- and OVA + SCW/IFA-primed con-
trol rats are comparable to each other and to that in 65-kD protein-pretreated,
OVA/IFA-primed rats, butthat the DTHreaction in 65-kD protein-pretreated, OVA
+ SCW/IFA-primed rats is significantly decreased.
Immunological Relationship between SCW and the Mycobacterial 65-kD Protein
To see whether SCW and 65-kD protein are immunologically interrelated, we
searched for crossreactivity at both the humoral and the cellular level. Recently, a
65-kD protein has been demonstrated in S pyogenes by mAbs (26), but no data are
available for the presence of 65-kD proteins in isolated cell walls of S. pyogenes. For
Coxiella, however, it has been described that isolationof cell walls resulted in enrich-
ment for the 65-kD heat shock protein (27).
The results of our protection experiments already suggest a similarity with re-
spect to T cell epitopes and Table IV shows further evidence: SCW-primed T cells
proliferate in vitro in response to 65-kD protein, and 65-kD protein-primed T cells
proliferate in response to SCW In addition, Table I shows that administration of
SCW in saline intraperitoneally in an arthritogenicdose induces65-kD protein-specific
T cell responses.
Also at the level of antibody recognition, SCW and 65-kD protein are related;
anti-65 kD sera react with SCW on immunoblots and vice versa(data not shown),
and of six anti-65-kD monoclonals, each recognizingdifferent epitopes in the mole-
cule (41-46), monoclonal E423 and 67-2 recognized SCW A control monoclonal
(WT31, directed against human T3, [42]) was negative. Table V shows the ELISA
results: the bindingofantiserum to its ownantigen andto the crossreactive antigen
could be blocked by preincubation of the serum with either antigen, albeit not in
all combinations to the same extent.VAN DEN BROEK ET AL.
TABLE IV
ImmunologicalRelationship at the TCell Level between the
Mycobacterial 65-kD Protein and SCW
Rats were immunized with 65 kD protein or SCW in IFA and the prolifera-
tive response of cells isolated from draining lymph nodes was measured 9 d
later. Proliferation was measured by [3H]thymidine incorporation during the
last 16 hof a 96-h culture with 65-kD protein, SCW, or mitogen as stimulus.
Proliferative responses are expressed as stimulation indices (amount of radio-
activity incorporated dueto stimulus Xdivided by that due to medium alone).
The values represent the mean ofquadruplicate cultures ofpooled lymph nodes
from three rats and the variation was always <10% .
* Muramic acid equivalents.
TABLE V
Serological Relationship between SCW and the Mycobacterial 65-kD Protein
The reactivity ofpolyclonal rat sera with aspecificity for SCWor 65-kD protein
were tested by ELISA and blocking studies for reactivity against 65-kD protein
and SCW. Sera and monoclonals were diluted 1:200. Inhibitor was added to
final concentrations ranging from 0 to 200 kg/ml. Sera were incubated for 16 h
at 37°C and a subsequent 2 h at 4°C, andwere centrifuged. Sups were tested
in an ELISA. All signals were corrected for nonspecific binding (binding ofsera
+/ - inhibitor to microtiterplates prepared as described but with omission of
the antigen-coating step).
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Discussion
Both clinical and experimental data provide evidence that bacteria play a role in
the induction or maintenance of arthritis (1-12). Two animal models used to study
this are AA (2) and SCWinduced arthritis (1). Both models are inducible in Lewis
rats, but differ in the way of induction: AA is induced by subcutaneous injection
Serum
specificity Coated Ag Inhibiting Ag
Percent inhibition at
inhibitor (ug/ml)
12.5 25 50
SCW SCW SCW 25 36 64
65-kD protein 0 19 30
65-kD SCW 0 6 20
65-kD protein 8 26 51
65-kD protein SCW SCW 34 60 58
65-kD protein 10 21 32
65-kD SCW 12 15 27
65-kD protein 22 56 71
Antigen Dose
Wglml
Proliferative
9 d after
65-kD protein/IFA
response
immunization with:
SCW/IFA IFA
SCW 6 12.1 48.1 1 .6
2 6.5 20.6 1.1
0.6 4.1 8.3 1 .2
65-kD protein 10 20.0 25.4 7 .9
3 10.5 11 .1 2 .7
1 4.6 6.4 1 .1
Con A 1 .3 143 .0 163.0 149.2460
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of a suspension of killed mycobacteria (1 mg) in oil, and SCW arthritis is induced
by an intraperitoneal injection of an aqueous suspension of SCW (10-15 mg). In
AA, apolyarthritisdevelops 2-3 wk afterinduction, which wanes after another 4wk,
whereafter rats are resistant to a subsequent AA induction. Immediately afterinjec-
tion of SCW, however, an acute systemic illness is observed that lasts for 3-5 d, fol-
lowedby achronicpolyarthritis on week 2-3 with aduration ranging from 2 to 6 mo.
Also with respect to the pathogenetic mechanism, the models are considered to
be different. In AA it is obvious that mycobacterium-specific Tlymphocytes, of which
some crossreact with cartilage, can be responsible for the disease (17-22), while in
SCW arthritis the most important role was thought to be played by antigen per-
sistingin the joint in concertwith macrophages trying to degrade the material (23,
47, 48). In addition, AA is transferable to naive rats by M. tuberculosis-specificlymph
node or spleen cells or by a T cell clone (17-22), whereas similar transfers in SCW
arthritis have not been described yet. More recent studies, however, suggested also
in SCWarthritis an importantifnot determining role for (SCW-specific) T lympho-
cytes(15, 16, 24, 49, andvan den Broek, M. F, M. C. J. vanBruggen, A. J. Severijnin,
and W. B. van den Berg, manuscript submitted for publication).
A recent study in theAA model (13) demonstrated that administration of a small
amount of an immunodominant mycobacterial protein, the 65-kD protein, in oil
to rats 35 d before arthritis induction, made those rats completely resistant to AA.
This 65-kD protein is immunologically related to a similarly sized ubiquitous bac-
terial common antigen (26) and shows homology with prokaryotic and eukaryotic
heat shock proteins (50). Because of the homology with proteins of other bacteria
and the clear relationship between bacterial infections of different kind and joint
inflammation, we tested this mycobacterial65-kD proteinwith respectto its capacity
to vaccinate against arthritis induced by group A streptococci, bacteria that areun-
related to mycobacteria.
Here we present, in concordance with the findings in AA, that SCW-induced ar-
thritis in Lewis rats can be prevented by pretreatment of the rats with the mycobac-
terial 65-kDprotein. Also, we show that protection by 65-kD protein is equally suc-
cessful when rats are injected with 65-kD protein 25, 15, or even as short as 5 d
before arthritis induction. This suggests that the protection takes at the most 5 d
to develop completely and lasts for 35 d or maybe even longer.
An obvious question arising from these observations is which mechanism could
be responsible for this. To address this question we analyzed the cellular and hu-
moral immune response to SCW in protected and control rats. Regarding the hu-
moral immune response, no difference in anti-SCW antibodies could be detected
between the protected or control rats, suggesting that anti-SCW antibodies are of
minor, if of any, importance with respect to expression of SCW arthritis. This is
in agreement with earlier studies in the SCW arthritis model (16, 51). A different
picture is obtained when the cellular immune response is analyzed. T cells from
successfully protected rats showed almost no proliferative response to SCW in vitro,
whileT cells from control arthritis rats displayed avigorous SCW-specific response.
This confirms the involvement of SCW-specific T lymphocytes in chronic SCW ar-
thritis (16, 24, 49, andvan den Broek, M. F., M. C. J. van Bruggen, A. J. Severijnen,
and WB. vanden Berg, manuscript submitted forpublication). Andbecause pretreat-
ment with 65-kDproteinhadno effect at allon zymosan-induced arthritis (nonspecificVAN DEN BROEK ET AL.
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inflammatory reaction) oron a DTH reaction to aprotein antigen (cellularimmune
response), thepossibilitythatthe 65-kD proteinactivity isanonspecificimmunosup-
pressive or andinflammatory one could be excluded.
Apeculiar observation is the suppression ofthe proliferative response to mitogen
in 65-kD protein-pretreated, SCWinjected rats. The explanation could be that by
intraperitoneal injection ofthe mycobacterial 65-kD heat shock protein, the rat is
primed for suppression ortoleranceto arthritogenicbacterial epitopes. After an SCW
injection in 65-kD protein-pretreated rats, suppression of SCWinduced arthritis
is therefore elicited, and, as immunosuppression often has nonspecific aspects in
its effectorphase, suppression ofthe mitogen-driven proliferation is also seen. This
explanation is supported by the data shown.in Table III: the OVA-specific DTH
reaction is only suppressed in 65-kD protein-pretreated rats when these rats are
"challenged" with SCW.
The reason why pretreatment with wholemycobacteria insteadofthe isolated im-
munodominant protein does not induce protection against SCWinduced arthritis,
butinducesan anaphylactickindofhypersensitivity, is not clearyet. This phenomenon
obviously does not occur in the same way for all bacterial stimuli, because pretreat-
ment with wholeS. pyogenes does not induce this lethal hypersensitivity to SCW but
rather primes. This lethal hypersensitivity reaction also indicates the immunolog-
icalrelationship betweensomeantigens presentin bothmycobacteria and streptococci.
Also, in other animal models for autoimmune diseases the induction oftolerance
tocertain disease-inducing epitopes has been demonstrated. In experimental allergic
encephalomyelitis (28, 29) and collagen-induced arthritis (30, 31), pretreatment with
fragments of the inductory protein (but not the inducing agent itself) or with the
intact protein when administered orally completely protected animals against the
disease, orat least delayed the onset and diminished the severity. Like in the study
presented here, in experimental allergic encephalomyelitis the myelin basic pro-
tein-specific T cell responseswere severely suppressed in protected Lewisrats while
T cell responses to irrelevant antigens were normal.
Compatible with these findings seemstobe the observation ofKohashi etal. (52),
who showed that AA-resistant F344 rats (conventional, CV, or specific pathogen-
free) became susceptible when kept at germ-free conditions. Upon recolonization
with live bacteria, the susceptibility to AA decreased again. One might conclude
from these data that certainantigens presenton endogenous bacteria may somehow
induce toleranceto bacterial arthritogenic epitopes. In addition, conventional F344
rats are resistant to SCWinduced arthritis and also, this resistance might be due
to active suppression ofSCWspecific and thus of crossreactive anticartilage T cell
responses (16, 25). Also, the latter observation supports the view of tolerance as a
mechanism for resistance.
Resistance to SCWinduced arthritis can be transferred into naive rats by spleen
cells from 65-kD protein-treated rats (Fig. 4), leaving a role for whether T cells
(antigen-specific), macrophages (nonspecific), or both are responsible for the pro-
tection. Thefact, however, thatisolatedT cells from spleens from 65-kD protein-pro-
tected rats were even more capable than unpurified spleen cells to transfer protec-
tion, strongly suggests a role for T cells alone.
Experimentsinothermodels suggest arole for antigen-specific suppressor Tlym-
phocytes (53-55). Ifalack oftolerance is the reason for arthritis susceptibility, this462
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then suggests in the mean time that the Lewis rat is defective in building tolerance
to certain bacterial epitopes or to antigens in general. The fact that most models
for autoimmune disease are inducible in the Lewis rat and often in the Lewis rat
only is at least not contradictory to this statement.
Our attempts to interfere with SCW-induced arthritis in a sense of curing were
not successful. Insteadof adecreasedjoint swelling, we observed an acute exacerba-
tion of the arthritis, which manifested itself as redness, swelling, and a complete
inability to walk, while before injection of 65-kD protein (50 p,g i.p.), an inferior
kind of walking was possible. The exacerbation occurred 4 d after 65-kD protein
administration and waned within 10-14 d. We observed this feature in an SCW-
induced arthritis that hadjust come to expression (15 d) and in a fully established
chronicphase(35 or 55 d). This observationwas notcompletely unexpected because
of our (56, 57, and van den Broek, M. F., M. C. J. van Bruggen, A. J. Severijnen,
and W. B. van den Berg, manuscript submitted for publication) experience and that
of others (58, 59)with reactivations ofjointinflammation in different arthritismodels.
Exacerbations of arthritis occur after systemic challenge with small amounts of the
relevant antigen and the expression thereofis dependent on antigen-specific T lym-
phocytes.
Tolerance inductionto SCW by 65-kD protein demandsimmunologicalsimilarity
between 65-kD protein and SCW This similarity is present both at the T cell and
at the humoral level. Looking at epitopes with the use of anti-65-kD monoclonals,
we found that (at least) two distinct 65-kD protein-specific epitopes were present
in SCW preparations. At the moment studies are undertaken to see whether the
minimal epitope as defined in AA (amino acid 180-188, [13]) also plays a similar
role in SCW-induced arthritis.
Summary
We report that streptococcal cell wall (SCW)-induced arthritisin rats, aT cell-de-
pendent chronic, erosive polyarthritis, can be preventedby pretreatment of the rats
with the mycobacterial 65-kD heat shock protein. This 65-kD protein shows exten-
sive amino acid homology with prokaryotic and eukaryotic 65-kD heat shock pro-
teins and is a ubiquitous bacterial common antigen.
Both theclinical and histopathologic manifestations ofthe arthritis were prevented
completely when rats were pretreated with 50 ttg of 65-kDprotein intraperitoneally
at 35, 25, 15, or 5 d before administration of SCW. In such protected rats, SCW-
specific T cell responses were suppressed, as compared with responses in arthritic
rats. Pretreatment with 65-kDprotein had no effect on theproduction of antibodies
against SCW, on a nonspecific inflammatory reaction (zymosan-induced arthritis),
or on general cellular immunity in vivo (delayed type hypersensitivity reaction to
a nonrelated protein antigen). Furthermore, the protection against SCW arthritis
was transferable by splenic T cells to naive recipients.
Our data show that pretreatment with the 65-kD mycobacterial heat shock pro-
tein protects rats against a subsequent bacterium-induced arthritis. This protection
is immunologically specific and resides in the lymphoid cell population.
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